Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Neonatal FeNO, risk factors, and respiratory morbidity in infants: A cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Pulmonary diffusing capacity measured by NO/CO transfer in Tunisian boys

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Lung compartment analysis assessed from N2 multiple-breath washout in children with cystic fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Exhaled Nitric Oxide in Premature and Mature Infants During the First Months of Life

    Research output: Contribution to journalReviewResearchpeer-review

  2. Challenges in conducting paediatric trials with off-patent drugs

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Increased colon transit time and faecal load in irritable bowel syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Reproducibility of Glucose Fluctuations Induced by Moderate Intensity Cycling Exercise in Persons with Type 1 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Respiratory symptoms in infancy are more common in premature infants. Nitric oxide (NO) is involved in prenatal and neonatal lung development. Measurement of exhaled NO is easy and well-tolerated by neonates. We investigated whether neonatal exhaled NO can be used to predict subsequent respiratory symptoms. Furthermore, we sought to determine prenatal and postnatal factors associated with increased respiratory symptom risk during the first year of life in premature and mature infants.

METHODS: Tidal fractional exhaled NO (FeNO) was measured in a birth cohort (n = 135) of premature and mature infants, up to six times during the first month of life. Primary outcomes were troublesome respiratory symptoms (TRS) and doctor-diagnosed asthmatic bronchitis (AB) at 1 year of age.

FINDINGS: The correlation between FeNO and TRS changed significantly in an age-dependent pattern in moderately premature infants (p = .02). Moderately premature infants with a low FeNO of 2 ppb on postnatal Day 3 had a 48% (95% confidence interval [CI]: 17%-80%) probability of TRS, compared with a probability of 12% (95% CI: 1%-64%) for otherwise similar infants with a FeNO of 11 ppb. Respiratory syncytial virus infection and parental smoking significantly increased the TRS risk in premature infants. Parental asthma and maternal antibiotic use during pregnancy significantly increased the TRS risk in mature infants.

INTERPRETATION: An age-specific association between neonatal FeNO and respiratory symptoms was seen in moderately premature infants. TRS risk was associated with postnatal factors in premature and prenatal factors in mature infants.

Original languageEnglish
JournalPediatric Pulmonology
Volume56
Issue number10
Pages (from-to)3174-3182
Number of pages9
ISSN8755-6863
DOIs
Publication statusPublished - Oct 2021

    Research areas

  • biomarkers, infant, nitric oxide, premature, respiratory system

ID: 66949667